Scientists usually study the molecular machinery that controls gene expression from the perspective of a linear, two-dimensional genome—even though DNA and its bound proteins function in three ...
Good morning, everyone, and thank you for joining us on the call today. This morning, FuelCell Energy, Inc. released our financial results for 2026, and our earnings press release is available on the ...
Dr. William Chen discusses NAMs, AI, and the future of risk assessment for cell-based foods With cultivated meat emerging as one of the most promising innovations in alternative proteins, regulators ...
Join Grace Webb, Matt Green and awesome astronaut Tim Peake on a fact-finding mission to make Moon: The Movie, starring the one and only moon from Horrible Science! Show more Help turn the moon from ...
The arterial vasculature is the second most frequently calcified structure in the human body after the skeleton. Calcification of the aorta and aortic valves occurs in most individuals in westernized ...
Pilatus Biosciences, Inc., a clinical-stage biopharmaceutical company developing novel metabolic checkpoint immunotherapies for liver and gastrointestinal cancers, today announced the first patient ...
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at ...
In an interview with pv magazine, Empa scientist Mirjana Dimitrievska explains that the CIGS photovoltaic technology, while promising for efficiency and flexible applications, faces persistent ...
BACKGROUND: Aortic valve calcification increases leaflet stiffness and contributes to the development of calcific aortic valve disease. The molecular and cellular mechanisms underlying calcification ...
Hi. Good morning, everyone. I'm Ellie Merle, one of the biotech analysts here at Barclays. Thank you for joining us here in Sunny Miami. Very happy to have 4D Molecular Therapeutics here with us today ...
Detailed price information for Biorestorative Therapies Inc (BRTX-Q) from The Globe and Mail including charting and trades.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果